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Table 1. Early clinical and 2-year outcome data divided into 3 groups according to their aEEG pattern at around six hours postnatal age 
   CNV (n=15) DNV (n=18) SEVP (n=14) CNV vs DNV DNV vs SEVP 
 Gestational age weeks             M(IQR) 39.7(38-41.1) 40.4(38.9-41.1) 39.6(38.6-39.9) NS NS 
 Birthweight kg                           M(IQR) 3.08(2.72-3.74) 3.56(3.15-3.89) 3.4(3.15-3.67) NS NS 
 CPR during resuscitation                n=             4 3 11 NS 0.001 





Apgar 10                                     M(IQR)     5(5,6)     5(4.3,6)   4(1,6.3) NS NS 
pH 1st hour                                M(IQR)  6.89(6.86-6.99) 6.99(6.87-7.11) 6.91(6.83-7.09) NS NS 
BE 1st hour (mmol/L)               M(IQR) 
Ventilation at 10 mins             % of n 
17.9(13.6-19.2) 
   73% 
17.6(11.93-20.23) 
  82% 
15(12.3-18.9) 













           III:n= 1 
I:n= 1 
II:n=14 












*Lactate  ≤5mmol/L                  M(IQR)    8.1(4.4-12.3) 4.1(2.4-13.2) 8.38(6.3-22.7) NS 0.037 
Troponin T at 72h                      M(IQR) 59(39-77) 96(54-144) 119(58-469) NS NS 
LDH at 72h                                  M(IQR) 756(617-1118) 745(570-1580) 740(594-1547) NS NS 
Duration in h of inotropy         M(IQR) 0(0-33) 27(0-76) 44(11-79) NS NS 
Short-term 
neurology 
TTNT (h) for SEVP group           M(IQR) NA NA   18.5 (12-56) NA NA  
Seizure prevalence n/group (%) 1/15(7%) 9/18 (50%) 14/14 (100%) 0.05 0.002  





Deaths                                                n= 0 0 3 NS 0.09 
Children in each aEEG group          n= 15 17 9   
Cognition Index                          M(IQR) 95(92.5-100) 100(90-105) 90(62.5-98.8) NS  0.034 
     (n=41)      
Cognition Index 70-84 (n)                    2 2 1   
     n=41 Cognition Index <70 (n)                        0 0 1   
 Motor Index                                M(IQR)      91(85.5-95.5)  88(83.5-97) 82(50.5-89.5) NS  0.093 
      (n=41)      
 Motor Index 70-84 (n)                        2 4 3   
 Motor Index <70 (n)                 0 0 2   
       Seizures on AEDs                               n= 0 1 0 NA         NA 
 Cerebral palsy                                    n= 0 1 2 NA         NA 
 Individual Cogn / Motor score  a)95/85 a)70/46, b)60/64   
 Abnormal outcome survivors          n= 3 4 5 NS 0.02 
 
Individual Cogn / Motor score  
a) 95/82 











   
 
Total poor outcome  n (% of group) 3(20%) 4(22%) 8(57%) NS 0.02 
Total good outcome n (% of group) 12(80%) 14(78%) 6(43%)   
 
AED: antiepileptic drug; BE: base excess; CNV: continuous normal voltage; CPR: cardiopulmonary resuscitation; DNV: discontinuous normal 
voltage; h: hours; HIE : hypoxic ischemic encephalopathy grading I =mild, II=moderate, III=severe, IQR: interquartile range; *Duration in hours 
when lactate has declined to  ≤5mmol/L; LDH: lactate dehydrogenase; M: median; MRI: magnetic resonance imaging; n; number; NA: not 
applicable; NS: not significant; SEVP: severe aEEG background patterns (Burst Suppression, Low Voltage or Flat Trace) ; TTNT: time to 
« normal » trace during cooling which is CNV or DNV). 
  
Table 2 Stepwise linear regression 
 
Cognition Score, Dependent Variable for combined DNV and SEVP group, survivorsa 
Model       R=0.828 n=29 B Std.Error t Sig 
Constant 104.262 2.106 49.514 0.000 
MRI (0-11)  -3.375 0.475 -7.104 0.000 
Excluded variables, none to enter with significance <0.100   
 
Motor Score, Dependent Variable for combined DNV and SEVP group, survivorsb 
Model      R=0. 649 n=29 B Std.Error t Sig 
Constant 96.932 3.048 31.798 0.000 
MRI (0-11) -3.154 0.688 -4.593 0.000 
Excluded variables, none to enter with significance <0.100  
 
Cognition Score, Dependent Variable, SEVP group only, survivorsa 
Model       R=0.939 n=11 B Std.Error t Sig 
Constant 106.697 2.261 47.183 0.000 
Time To Normal Trace in hours -0.641 0.074 -8.609 0.000 
Excluded variables, none to enter with significance <0.100 
 
Motor Score, Dependent Variable , SEVP group only, survivorsb  
Model       R=0.796 n=11 B Std.Error t Sig 
Constant 101.975 5.694 17.908 0.000 
Time To Normal Trace in hours -0.712 0.163 -4.36 0.001 
Excluded variables, none to enter with significance <0.100 
a,b These regressions were also run including the 3 that died in the SEVP group,  allocating them  a numeric value one point  lower  than the 
subjects testable. This did not change the order by which the variables entered the regression but strenghtened the model.   
Cognition Score or Motor Score as Dependent Variables, CNV group n=15  
There was no prediction of either cognitive or motor outcomes in the CNV group using the listed variables in linear regression analysis. 
Five variables were used in all regressions: Birth weight in grams, number of antiepileptic drugs used, worst LDH during first 72h of life, 
numbers of hours with inotropic support and MRI (0-11). In addition for SEVP group: Time To “Normal Trace”  
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TimeToNormalTrace = 116,73 - 1,042 * Motorindex+44; R^2 = ,775
Figure 1a 
Figure 1b 
Figure 1c 
